Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Bullboard Posts
Comment by threefiftynineon Mar 16, 2020 5:30am
286 Views
Post# 30811383

RE:----VAXIL BIO HAS THE CURE----

RE:----VAXIL BIO HAS THE CURE----
THIS VACCINE WORKS WITH COVID19 : ATEL AVIV, IsraelResearchers at Vaxil Biotherapeutics, along with scientists at the University of Tel Aviv, have developed a revolutionary vaccine targeted to train cancer patients' own bodies to seek out and destroy tumor cells. If successful, this groundbreaking modality could change the way doctors treatand the way patients viewfuture cancer treatment. The unique therapy targets a molecule found in 90 percent of all cancers, and could provide a universal injection that allows patients' immune systems to fight off common cancers including breast and prostate cancer. Preliminary results from early clinical trials held at the Hadassah University Medical Center in Jerusalem have shown the vaccine can trigger an immune response in patients and reduce levels of disease. But before the new vaccine is crowned a miracle drug, scientists hope to conduct larger trials in patients to prove the vaccine can be effective against a range of different cancers. A total of 10 patients suffering from multiple myeloma, a form of blood cancer, received the vaccine at the Hadassah center, Vaxil reported. Seven of the patients have now finished the treatment and all of them had greater immunity against cancer cells than they did before they were given the vaccine. Three of these patients following the treatment are free of detectable cancer, Vaxil stated.
Bullboard Posts